Logan A. Gaudet, Lena Rybka, Emmanuel Mandonnet, Emmanuelle Volle, Marion Barberis, Roel Jonkers, Adrià Rofes
Understanding lexico-semantic processing is crucial for dissecting the complexities of language and its disorders. Relatedness-based measures, or those which investigate the degree of relatedness in meaning between either task items or items produced by participants, offer the opportunity to harness novel computational and analytical techniques from cognitive network science. Recognizing the need to deepen our understanding of lexico-semantic deficits through diverse experimental and analytical approaches, this review explores the use of such measures in research into language disorders. A comprehensive search of four electronic databases covering publications from the last 11 years (October 2013–September 2024) identified 38 original experimental studies employing relatedness-based measures in populations with language disorders or other neurological conditions. Articles were examined for the types of tasks used, populations studied, item selection methods and analytical approaches. The predominant use of category fluency tasks emerged across studies, with a notable absence of relatedness judgement tasks or comparable paradigms. Commonly discussed populations included individuals with post-stroke aphasia, mild cognitive impairment and schizophrenia. Analytical methods varied significantly, ranging from more traditional approaches of clustering and switching to more sophisticated computational techniques. Despite the evident utility of category fluency tasks in research and clinical settings, the review underscores a critical need to diversify experimental paradigms and probe lexico-semantic processing in a more multifaceted manner. A broadened approach in future language disorder research should incorporate innovative analytical techniques, investigations of neural correlates and a wider array of tasks employing relatedness-based measures already present in healthy populations.
{"title":"Leveraging relatedness-based measures in people with language disorders: A scoping review","authors":"Logan A. Gaudet, Lena Rybka, Emmanuel Mandonnet, Emmanuelle Volle, Marion Barberis, Roel Jonkers, Adrià Rofes","doi":"10.1111/jnp.12405","DOIUrl":"10.1111/jnp.12405","url":null,"abstract":"<p>Understanding lexico-semantic processing is crucial for dissecting the complexities of language and its disorders. Relatedness-based measures, or those which investigate the degree of relatedness in meaning between either task items or items produced by participants, offer the opportunity to harness novel computational and analytical techniques from cognitive network science. Recognizing the need to deepen our understanding of lexico-semantic deficits through diverse experimental and analytical approaches, this review explores the use of such measures in research into language disorders. A comprehensive search of four electronic databases covering publications from the last 11 years (October 2013–September 2024) identified 38 original experimental studies employing relatedness-based measures in populations with language disorders or other neurological conditions. Articles were examined for the types of tasks used, populations studied, item selection methods and analytical approaches. The predominant use of category fluency tasks emerged across studies, with a notable absence of relatedness judgement tasks or comparable paradigms. Commonly discussed populations included individuals with post-stroke aphasia, mild cognitive impairment and schizophrenia. Analytical methods varied significantly, ranging from more traditional approaches of clustering and switching to more sophisticated computational techniques. Despite the evident utility of category fluency tasks in research and clinical settings, the review underscores a critical need to diversify experimental paradigms and probe lexico-semantic processing in a more multifaceted manner. A broadened approach in future language disorder research should incorporate innovative analytical techniques, investigations of neural correlates and a wider array of tasks employing relatedness-based measures already present in healthy populations.</p>","PeriodicalId":197,"journal":{"name":"Journal of Neuropsychology","volume":"19 2","pages":"299-337"},"PeriodicalIF":1.8,"publicationDate":"2024-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jnp.12405","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142833292","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Hanne Huygelier, Nora Tuts, Karla Michiels, Eline Note, Fabienne Schillebeeckx, Jos Tournoy, Vero Vanden Abeele, Raymond van Ee, Céline R. Gillebert
Spatial neglect is a post-stroke attention deficit for which there is no evidence-based intervention. Immersive virtual reality (IVR) may increase treatment efficacy, as it allows to train spatial attention in a rich environment. This study evaluated the efficacy and feasibility of an IVR patient-tailored training (HEMIRehApp). Using a cross-over design, an active (spatially biased) and placebo (spatially unbiased) IVR intervention were compared. We aimed to recruit 8 per-protocol left-sided neglect patients. The primary outcome was response times on the Posner cueing task. To evaluate feasibility, we documented the number of recruited patients, cybersickness and patients' experience with HEMIRehApp. After 2 years of recruitment, we were able to enrol 6 patients, of whom 2 completed the full protocol. The target sample size was not feasible due to a lower than expected prevalence of left-sided neglect and a higher than expected drop-out rate. The planned group-level analysis was therefore replaced by a single-case analysis. The results in the 2 per-protocol cases suggest a superior effect of spatially biased IVR training than unbiased IVR training inside IVR. IVR training was feasible as all 6 enrolled patients were able to complete 10 IVR training sessions, but the cross-over protocol itself was unfeasible. While the low sample size prevented us from conclusively evaluating the efficacy of HEMIRehApp, our preliminary single-case results suggest that neglect patients were able to improve attentional orientation towards eccentric target locations in IVR. Follow-up studies are needed to further validate these findings.
{"title":"The efficacy and feasibility of an immersive virtual reality game to train spatial attention orientation after stroke: A stage 2 report","authors":"Hanne Huygelier, Nora Tuts, Karla Michiels, Eline Note, Fabienne Schillebeeckx, Jos Tournoy, Vero Vanden Abeele, Raymond van Ee, Céline R. Gillebert","doi":"10.1111/jnp.12403","DOIUrl":"10.1111/jnp.12403","url":null,"abstract":"<p>Spatial neglect is a post-stroke attention deficit for which there is no evidence-based intervention. Immersive virtual reality (IVR) may increase treatment efficacy, as it allows to train spatial attention in a rich environment. This study evaluated the efficacy and feasibility of an IVR patient-tailored training (HEMIRehApp). Using a cross-over design, an active (spatially biased) and placebo (spatially unbiased) IVR intervention were compared. We aimed to recruit 8 per-protocol left-sided neglect patients. The primary outcome was response times on the Posner cueing task. To evaluate feasibility, we documented the number of recruited patients, cybersickness and patients' experience with HEMIRehApp. After 2 years of recruitment, we were able to enrol 6 patients, of whom 2 completed the full protocol. The target sample size was not feasible due to a lower than expected prevalence of left-sided neglect and a higher than expected drop-out rate. The planned group-level analysis was therefore replaced by a single-case analysis. The results in the 2 per-protocol cases suggest a superior effect of spatially biased IVR training than unbiased IVR training inside IVR. IVR training was feasible as all 6 enrolled patients were able to complete 10 IVR training sessions, but the cross-over protocol itself was unfeasible. While the low sample size prevented us from conclusively evaluating the efficacy of HEMIRehApp, our preliminary single-case results suggest that neglect patients were able to improve attentional orientation towards eccentric target locations in IVR. Follow-up studies are needed to further validate these findings.</p>","PeriodicalId":197,"journal":{"name":"Journal of Neuropsychology","volume":"19 2","pages":"338-389"},"PeriodicalIF":1.8,"publicationDate":"2024-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142816754","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mohamad El Haj, Dimitrios Kapogiannis, Claire Boutoleau-Bretonnière
Autobiographical memory is diminished in patients with behavioural variant of frontotemporal dementia (bvFTD), and research has focused on the hampered ability of patients to retrieve specific memories. In this study, we implemented a methodology seeking to provide a qualitative analysis of autobiographical specificity. We invited patients with bvFTD and control participants to retrieve autobiographical memories and we distinguished between specific, categoric, extended and semantic autobiographical retrieval. The analysis demonstrated that patients with bvFTD produced more categoric than specific, extended or semantic memories. Thus, despite the decreased ability to retrieve specific memories, an increased ability to produce categoric memories can be observed in patients with bvFTD. These results support a positive view according to which autobiographical retrieval in bvFTD is not solely characterized by over-generality, but also by increased retrieval of categoric memories. Categoric memories, albeit lacking uniqueness, nevertheless, involve retrieval of similar or related events upon which patients may draw knowledge related to their self-image and life story.
{"title":"‘I still remember’: Increased categoric autobiographical memories in behavioural variant of frontotemporal dementia","authors":"Mohamad El Haj, Dimitrios Kapogiannis, Claire Boutoleau-Bretonnière","doi":"10.1111/jnp.12404","DOIUrl":"10.1111/jnp.12404","url":null,"abstract":"<p>Autobiographical memory is diminished in patients with behavioural variant of frontotemporal dementia (bvFTD), and research has focused on the hampered ability of patients to retrieve specific memories. In this study, we implemented a methodology seeking to provide a qualitative analysis of autobiographical specificity. We invited patients with bvFTD and control participants to retrieve autobiographical memories and we distinguished between specific, categoric, extended and semantic autobiographical retrieval. The analysis demonstrated that patients with bvFTD produced more categoric than specific, extended or semantic memories. Thus, despite the decreased ability to retrieve specific memories, an increased ability to produce categoric memories can be observed in patients with bvFTD. These results support a positive view according to which autobiographical retrieval in bvFTD is not solely characterized by over-generality, but also by increased retrieval of categoric memories. Categoric memories, albeit lacking uniqueness, nevertheless, involve retrieval of similar or related events upon which patients may draw knowledge related to their self-image and life story.</p>","PeriodicalId":197,"journal":{"name":"Journal of Neuropsychology","volume":"19 2","pages":"247-255"},"PeriodicalIF":1.8,"publicationDate":"2024-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142805759","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Amandine Décombe, Chiara Scarampi, Elora Malleville, Delphine Capdevielle, Sam J. Gilbert, Stéphane Raffard
Cognitive offloading refers to the use of physical action and the external environment to simplify mental demand. One form of this—intention offloading—involves the use of external reminders to support delayed intentions. Both beliefs of poor memory ability and a preference to avoid cognitive effort lead to offloading intentions rather than using internal memory. Schizophrenia is a population with deficits in prospective memory and to overcome this difficulty, neuropsychological interventions can propose external aids such as reminders. However, it is unknown what motivates individuals with schizophrenia to spontaneously use reminders. Twenty-seven individuals with schizophrenia and twenty-seven non-clinical individuals were recruited to perform a prospective memory task, with two levels of difficulty, by deciding whether to use reminders or their internal memory. The proportion of reminder use, performance (hits and errors), subjective effort and metacognitive beliefs were recorded. The results show a non-optimal use of reminders in the schizophrenia group: this group used more reminders than the non-clinical group when the task was easy but did not increase reminder usage when the task became more difficult. Individuals with schizophrenia perceived the task to be more effortful than the non-clinical individuals in the easy task, but also had a high estimation of their memory ability. Reminder usage in schizophrenia is atypical and non-optimal. This may relate to effort and metacognition but the direct influence of these factors remains to be demonstrated. The overall results open perspectives on the neuropsychological treatment of prospective memory in this population.
{"title":"Non-optimal cognitive offloading in schizophrenia in a prospective memory task: Influence of both metacognitive beliefs and cognitive effort avoidance","authors":"Amandine Décombe, Chiara Scarampi, Elora Malleville, Delphine Capdevielle, Sam J. Gilbert, Stéphane Raffard","doi":"10.1111/jnp.12399","DOIUrl":"10.1111/jnp.12399","url":null,"abstract":"<p>Cognitive offloading refers to the use of physical action and the external environment to simplify mental demand. One form of this—intention offloading—involves the use of external reminders to support delayed intentions. Both beliefs of poor memory ability and a preference to avoid cognitive effort lead to offloading intentions rather than using internal memory. Schizophrenia is a population with deficits in prospective memory and to overcome this difficulty, neuropsychological interventions can propose external aids such as reminders. However, it is unknown what motivates individuals with schizophrenia to spontaneously use reminders. Twenty-seven individuals with schizophrenia and twenty-seven non-clinical individuals were recruited to perform a prospective memory task, with two levels of difficulty, by deciding whether to use reminders or their internal memory. The proportion of reminder use, performance (hits and errors), subjective effort and metacognitive beliefs were recorded. The results show a non-optimal use of reminders in the schizophrenia group: this group used more reminders than the non-clinical group when the task was easy but did not increase reminder usage when the task became more difficult. Individuals with schizophrenia perceived the task to be more effortful than the non-clinical individuals in the easy task, but also had a high estimation of their memory ability. Reminder usage in schizophrenia is atypical and non-optimal. This may relate to effort and metacognition but the direct influence of these factors remains to be demonstrated. The overall results open perspectives on the neuropsychological treatment of prospective memory in this population.</p>","PeriodicalId":197,"journal":{"name":"Journal of Neuropsychology","volume":"19 2","pages":"216-233"},"PeriodicalIF":1.8,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142646349","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Joel Simrén, Nicholas J. Ashton, Marc Suárez-Calvet, Henrik Zetterberg
<p>Recent developments in fluid and imaging biomarkers that reflect the key pathological hallmarks of Alzheimer's disease (AD)—deposits of extracellular amyloid-β (Aβ) and intracellular tau proteins—have transformed the perception of the disease in living individuals from a clinical syndrome to a biological continuum that begins prior to the onset of symptoms (Scheltens et al., <span>2021</span>). Over the past two decades, biomarker research has revealed that Aβ deposition and abnormal tau metabolism begin years before symptoms appear, following a predictable sequence of biological changes (Bateman et al., <span>2012</span>; Villemagne et al., <span>2013</span>). This suggests a prolonged preclinical phase of the disease. Biomarkers, which have greatly expanded our understanding of disease progression, are now routinely applied in clinical settings. These include Food and Drug Administration (FDA)-approved positron emission tomography (PET) imaging agents of Aβ plaques and tau aggregates, cerebrospinal fluid (CSF) measures of Aβ and phosphorylated tau (p-tau), and soon, plasma measures of tau forms phosphorylated at amino acid 217 (p-tau217).</p><p>As AD neuropathology is the defining hallmark of the disease (Hyman et al., <span>2012</span>), as well as being the target of emerging treatments, recently approved in some countries (Cummings et al., <span>2023</span>), it is reasoned that biomarkers that directly reflect these changes should be the defining features of the disease. This view was formally articulated in the recent publication of novel Alzheimer's Association diagnostic and staging criteria for AD, which suggest that the disease can be diagnosed when a so-called ‘Core 1’ biomarker of Aβ proteinopathy or phosphorylated and secreted tau is abnormal, resulting in a purely biological definition of the disease (Jack et al., <span>2024</span>). In prior years, studies have shown that PET detect Aβ (Clark et al., <span>2012</span>) and tau (Fleisher et al., <span>2020</span>) neuropathology with high (~90%) accuracy. CSF tests of Aβ42/40 and Aβ42/p-tau (Janelidze et al., <span>2017</span>) have been validated against amyloid PET with similar accuracy, and subsequently also neuropathology (Mattsson-Carlgren et al., <span>2022</span>). Over the past 5 years, an expanding body of research indicates that plasma p-tau217 can detect Aβ pathology with high accuracy (Ashton et al., <span>2023</span>, <span>2024</span>; Schindler et al., <span>2024</span>), which will improve the access to biological AD diagnoses in clinical settings beyond what health care systems are currently scaled to accommodate.</p><p>The recently published diagnostic and staging criteria (Jack et al., <span>2024</span>) are a development of the criteria published by the National Institute of Aging and Alzheimer's Association (NIA-AA) in 2018, which aimed to establish a common language for further research in the biological evolution of AD and its relation to resulting symptom
反映阿尔茨海默病(AD)关键病理特征的流体和成像生物标志物(细胞外淀粉样蛋白-β (a β)和细胞内tau蛋白沉积)的最新进展,已将活个体对该疾病的认知从临床综合征转变为在症状发作之前开始的生物连续体(Scheltens等人,2021)。在过去的二十年中,生物标志物研究表明,a β沉积和异常tau代谢在症状出现前几年就开始了,遵循可预测的生物学变化序列(Bateman等,2012;Villemagne et al., 2013)。这表明该疾病的临床前阶段较长。生物标志物,极大地扩展了我们对疾病进展的理解,现在被常规地应用于临床环境。这些包括美国食品和药物管理局(FDA)批准的Aβ斑块和tau聚集体的正电子发射断层扫描(PET)显像剂,脑脊液(CSF)测量Aβ和磷酸化tau (p-tau),以及很快,血浆测量氨基酸217磷酸化的tau形式(p-tau217)。由于阿尔茨海默病的神经病理学是该疾病的决定性标志(Hyman et al., 2012),也是一些国家最近批准的新兴治疗方法的目标(Cummings et al., 2023),因此有理由认为直接反映这些变化的生物标志物应该是该疾病的决定性特征。这一观点在最近发表的阿尔茨海默病协会的新AD诊断和分期标准中得到了正式阐述,该标准表明,当a β蛋白病或磷酸化和分泌的tau蛋白的所谓“Core 1”生物标志物异常时,可以诊断出该疾病,从而导致该疾病的纯生物学定义(Jack等人,2024)。前几年的研究表明,PET检测Aβ (Clark et al., 2012)和tau (Fleisher et al., 2020)神经病理学具有很高(~90%)的准确性。a - β42/40和a - β42/p-tau的脑脊液测试(Janelidze等人,2017)已经在淀粉样PET上得到了类似的准确性验证,随后也得到了神经病理学的验证(Mattsson-Carlgren等人,2022)。在过去的5年中,越来越多的研究表明血浆p-tau217可以高精度地检测Aβ病理(Ashton et al., 2023,2024;Schindler等人,2024),这将改善临床环境中生物AD诊断的可及性,超出目前卫生保健系统的规模。最近发表的诊断和分期标准(Jack et al., 2024)是对美国国家衰老与阿尔茨海默病协会(NIA-AA)于2018年发布的标准的发展,旨在为进一步研究阿尔茨海默病的生物进化及其与由此产生的症状学的关系建立一种共同语言(Jack et al., 2018)。与该文件一样,在最近的标准中,临床分期方案作为疾病定义的补充(Jack et al., 2024)。最近的标准还增加了一个生物学分期方案,表明tau PET(“Core 2生物标志物”;包括有前途的尽管是探索性的tau聚集体流体生物标志物;Horie等人,2023)与Aβ PET结合使用,用于对疾病进行生物学分期,因为tau聚集物与症状有更密切的关系(Ossenkoppele等人,2018)。在这些标准之前的另一个关键发展是,最近FDA全面批准了lecanemab (van Dyck等人,2023年)和donanemab (Sims等人,2023年),现在世界其他地区的其他几个监管机构也批准了这两种药物。这些试验依赖于谨慎使用基于生物标志物的纳入,确保个体具有治疗所针对的病理(即Aβ病理)。在一些早期失败的试验中,情况并非如此,在这些试验中,阿尔茨海默氏症是临床定义的,这意味着诊断与生物标志物状态无关。在其中一项试验中,相当大比例的研究参与者被发现为a β阴性(Salloway et al., 2014),因此可能被误诊。换句话说,为了成功地治疗疾病的生物学,疾病的定义必须基于其潜在的生物学。此外,血浆p-tau217和胶质纤维酸性蛋白(GFAP;一种反映胶质细胞激活的星形胶质蛋白)在临床试验中显示出对抗a β药物的反应,这表明它们可以用作靶标参与生物标志物(Pontecorvo等人,2022;Sims et al., 2023)。进一步支持这一点的是,脑脊液和成像生物标志物以及分子神经病理学的最新进展,使该领域能够获得更多关于神经心理学测量、症状学和生物标志物/神经病理学发现之间关系的知识。这些研究发现,通常与AD病理相关的经典遗忘综合征可能是由于边缘显性年龄相关性TDP-43脑病(LATE)所致(Nelson等)。 (2019)在很大比例的病例中,特别是在最年长的老年患者中。相反,原发性进行性失语(Bergeron等人,2018)、行为/执行障碍综合征(Ossenkoppele等人,2015)、皮质基底综合征(Lee等人,2011)和后皮质萎缩(Alladi等人,2007)等综合征也可能与AD的潜在病理有关。众所周知,个体可能表现为多种病理(Robinson et al., 2018),对病理有不同的认知恢复力(Stern, 2012),有疾病进展的遗传修饰因子(Van Cauwenberghe et al., 2016),或者具有与阿尔茨海默氏症不典型相关的症状(例如认知症状的波动,在路易体痴呆中很常见),这可以反映在临床阶段和生物学阶段的分离(Jack et al., 2024)。然而,再一次,如果阳性生物标志物与临床表现不一致,这并不意味着疾病不存在。另一方面,需要仔细的临床判断来确定哪种病理最可能解释症状。阿尔茨海默病生物学定义的批评者表示,这些新标准将能够检测出患有阿尔茨海默病的无症状个体,尽管尚不确定他们最终是否会因该疾病而出现症状。然而,阿尔茨海默病协会的标准强调,目前AD可以但不应该在没有认知症状(临床阶段1)的个体中被诊断出来(Jack et al., 2024),同样的推理也适用于大多数有主观认知症状的个体(即没有客观损害;临床阶段2),因为没有批准的治疗方法用于这一群体,并且这些病例的疾病患病率较低,因此阳性预测值较低,导致更高的假阳性结果和不必要的调查和焦虑(Hansson &;杰克,2024)。如果正在进行的临床前AD试验取得成功,这种情况可能会改变(Rafii等人,2023),导致与心血管疾病(例如治疗高血压或降脂)或2型糖尿病(治疗无症状高血糖)相当的情况。在缺乏此类治疗方法的情况下,我们认为目前应仅在有症状的个体中使用生物标志物诊断AD,同时进行仔细的临床评估,因为这种疾病的检测前概率较高,并且后果可行(例如,有症状的治疗和在一些国家的疾病改善治疗)。正在制定关于如何以及何时诊断AD的具体工作流程和基于场景的指南。未来的研究非常重要,以增加对AD是某一患者症状的原因的信心,包括验证反映tau聚集体的液体生物标志物(即提供与tau PET相似的信息)。脑脊液测量微管结合区(MTBR) tau已显示出可喜的结果(Horie等人,2023;Salvado等,2024)和脑脊液或血浆中氨基酸205处的p-tau (p-tau205) (Gobom等,2022;Lantero-Rodriguez et al., 2024;Montoliu-Gaya, Alosco等,2023;Montoliu-Gaya, Benedet等,2023),它比反映
{"title":"Alzheimer's disease—Biomarkers, clinical evaluation or both?","authors":"Joel Simrén, Nicholas J. Ashton, Marc Suárez-Calvet, Henrik Zetterberg","doi":"10.1111/jnp.12401","DOIUrl":"10.1111/jnp.12401","url":null,"abstract":"<p>Recent developments in fluid and imaging biomarkers that reflect the key pathological hallmarks of Alzheimer's disease (AD)—deposits of extracellular amyloid-β (Aβ) and intracellular tau proteins—have transformed the perception of the disease in living individuals from a clinical syndrome to a biological continuum that begins prior to the onset of symptoms (Scheltens et al., <span>2021</span>). Over the past two decades, biomarker research has revealed that Aβ deposition and abnormal tau metabolism begin years before symptoms appear, following a predictable sequence of biological changes (Bateman et al., <span>2012</span>; Villemagne et al., <span>2013</span>). This suggests a prolonged preclinical phase of the disease. Biomarkers, which have greatly expanded our understanding of disease progression, are now routinely applied in clinical settings. These include Food and Drug Administration (FDA)-approved positron emission tomography (PET) imaging agents of Aβ plaques and tau aggregates, cerebrospinal fluid (CSF) measures of Aβ and phosphorylated tau (p-tau), and soon, plasma measures of tau forms phosphorylated at amino acid 217 (p-tau217).</p><p>As AD neuropathology is the defining hallmark of the disease (Hyman et al., <span>2012</span>), as well as being the target of emerging treatments, recently approved in some countries (Cummings et al., <span>2023</span>), it is reasoned that biomarkers that directly reflect these changes should be the defining features of the disease. This view was formally articulated in the recent publication of novel Alzheimer's Association diagnostic and staging criteria for AD, which suggest that the disease can be diagnosed when a so-called ‘Core 1’ biomarker of Aβ proteinopathy or phosphorylated and secreted tau is abnormal, resulting in a purely biological definition of the disease (Jack et al., <span>2024</span>). In prior years, studies have shown that PET detect Aβ (Clark et al., <span>2012</span>) and tau (Fleisher et al., <span>2020</span>) neuropathology with high (~90%) accuracy. CSF tests of Aβ42/40 and Aβ42/p-tau (Janelidze et al., <span>2017</span>) have been validated against amyloid PET with similar accuracy, and subsequently also neuropathology (Mattsson-Carlgren et al., <span>2022</span>). Over the past 5 years, an expanding body of research indicates that plasma p-tau217 can detect Aβ pathology with high accuracy (Ashton et al., <span>2023</span>, <span>2024</span>; Schindler et al., <span>2024</span>), which will improve the access to biological AD diagnoses in clinical settings beyond what health care systems are currently scaled to accommodate.</p><p>The recently published diagnostic and staging criteria (Jack et al., <span>2024</span>) are a development of the criteria published by the National Institute of Aging and Alzheimer's Association (NIA-AA) in 2018, which aimed to establish a common language for further research in the biological evolution of AD and its relation to resulting symptom","PeriodicalId":197,"journal":{"name":"Journal of Neuropsychology","volume":"19 2","pages":"165-171"},"PeriodicalIF":1.8,"publicationDate":"2024-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jnp.12401","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142613232","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Surface dyslexia and dysgraphia are considered diagnostic features of semantic variant primary progressive aphasia (svPPA) and are useful signs in English, a language whose attributes afford numerous opportunities to observe these phenomena. This, however, is not the case in many languages, including Italian, that have high transparency between orthography and phonology, making surface reading and spelling errors scarce. This creates a problem in applying the diagnostic recommendations for svPPA in such languages. Surface dyslexia and dysgraphia are examples of ‘regularization’ errors in which semantic knowledge loss leads to a failure to recognize exceptions that do not follow standard rules of pronunciation. Another form of regularization involves the incorrect inflection of irregular verbs using the rules that govern regular verbs. Unlike irregularly pronounced words, Italian, as with many languages, has numerous irregular verbs. The Italian Verb Inflection Test (IVIT) was developed to test the hypothesis that svPPA would regularize irregular verbs when inflecting them into two Italian past tenses. Results confirmed that people with svPPA made a significantly greater proportion of regularization errors compared to people with typical Alzheimer's disease or logopenic variant PPA. Without recourse to the other diagnostic features of PPA subgroups, the IVIT on its own could separate svPPA from these other two groups with 70% sensitivity and ~ 80% specificity. Regularization of irregular verb inflection offers a solution to the problem of applying the surface dyslexia/dysgraphia criterion for svPPA diagnosis in Italian.
{"title":"Resolving the problem of surface dyslexia in Italian through inflection of irregular verbs","authors":"Daniele Licciardo, Valeria Isella, Elisa Canu, Marta Forestiero, Veronica Castelnovo, Stefania Valsecchi, Federica Agosta, Massimo Filippi, Ildebrando Appollonio, Peter J Nestor","doi":"10.1111/jnp.12400","DOIUrl":"10.1111/jnp.12400","url":null,"abstract":"<p>Surface dyslexia and dysgraphia are considered diagnostic features of semantic variant primary progressive aphasia (svPPA) and are useful signs in English, a language whose attributes afford numerous opportunities to observe these phenomena. This, however, is not the case in many languages, including Italian, that have high transparency between orthography and phonology, making surface reading and spelling errors scarce. This creates a problem in applying the diagnostic recommendations for svPPA in such languages. Surface dyslexia and dysgraphia are examples of ‘regularization’ errors in which semantic knowledge loss leads to a failure to recognize exceptions that do not follow standard rules of pronunciation. Another form of regularization involves the incorrect inflection of irregular verbs using the rules that govern regular verbs. Unlike irregularly pronounced words, Italian, as with many languages, has numerous irregular verbs. The Italian Verb Inflection Test (IVIT) was developed to test the hypothesis that svPPA would regularize irregular verbs when inflecting them into two Italian past tenses. Results confirmed that people with svPPA made a significantly greater proportion of regularization errors compared to people with typical Alzheimer's disease or logopenic variant PPA. Without recourse to the other diagnostic features of PPA subgroups, the IVIT on its own could separate svPPA from these other two groups with 70% sensitivity and ~ 80% specificity. Regularization of irregular verb inflection offers a solution to the problem of applying the surface dyslexia/dysgraphia criterion for svPPA diagnosis in Italian.</p>","PeriodicalId":197,"journal":{"name":"Journal of Neuropsychology","volume":"19 2","pages":"234-246"},"PeriodicalIF":1.8,"publicationDate":"2024-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jnp.12400","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142613238","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Biological, clinicobiological and clinical conceptions of Alzheimer's disease and related dementias are being promoted simultaneously to different practical ends. The co-existence of contemporary conceptions and the ‘scary label’ associated with older diagnostic criteria create the possibility of misunderstanding and harm. In this comment, we argue in favour of socio-ethical interventions targeted to health workers and the general public so as to lower the uncertainties introduced by contemporary diagnostic criteria and to articulate how they relate to established criteria.
{"title":"Reducing confusion surrounding expert conceptions of Alzheimer's and dementia: A practical analysis","authors":"Timothy Daly, Ignacio Mastroleo","doi":"10.1111/jnp.12398","DOIUrl":"10.1111/jnp.12398","url":null,"abstract":"<p>Biological, clinicobiological and clinical conceptions of Alzheimer's disease and related dementias are being promoted simultaneously to different practical ends. The co-existence of contemporary conceptions and the ‘scary label’ associated with older diagnostic criteria create the possibility of misunderstanding and harm. In this comment, we argue in favour of socio-ethical interventions targeted to health workers and the general public so as to lower the uncertainties introduced by contemporary diagnostic criteria and to articulate how they relate to established criteria.</p>","PeriodicalId":197,"journal":{"name":"Journal of Neuropsychology","volume":"19 2","pages":"158-164"},"PeriodicalIF":1.8,"publicationDate":"2024-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jnp.12398","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142491712","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
María A. Sosa, Eduardo J. Pedrero-Pérez, José M. Ruiz-Sánchez de León
This study introduces the translation and validation of the Prefrontal Symptoms Inventory (PSI) into English, aiming to provide an ecologically valid tool for assessing prefrontal symptoms in English-speaking populations in the United States. The prefrontal cortex (PFC) plays a crucial role in executive functions and other higher-order cognitive processes, with dysfunctions in this area associated with various cognitive, emotional and behavioural changes. Despite the existence of established tools like the Dysexecutive Questionnaire (DEX), the PSI addresses limitations found in the literature, presenting a novel ecologically valid tool for assessing prefrontal symptoms. The current study, involving 226 English-speaking participants, lays a foundational step for validating the PSI for use in a new population. Semi-confirmatory factorial analysis revealed a unidimensional structure, mirroring the Spanish version with robust fit indicators. Additionally, in assessing convergent validity, the abbreviated version (PSI-20) exhibited high correlations with DEX scores and moderate correlations with Psychological Stress Scale and General Health Questionnaire-12 scores. These findings align with previous reports, supporting the PSI-20's measurement of similar constructs related to prefrontal cortex activity and mental health components. The results of this study overall highlight the PSI's potential contribution to advancing prefrontal symptom evaluation in clinical and non-clinical settings.
{"title":"Translation and validation of the abbreviated Prefrontal Symptoms Inventory (PSI-20): A tool for assessing prefrontal symptoms in English-speaking populations","authors":"María A. Sosa, Eduardo J. Pedrero-Pérez, José M. Ruiz-Sánchez de León","doi":"10.1111/jnp.12397","DOIUrl":"10.1111/jnp.12397","url":null,"abstract":"<p>This study introduces the translation and validation of the Prefrontal Symptoms Inventory (PSI) into English, aiming to provide an ecologically valid tool for assessing prefrontal symptoms in English-speaking populations in the United States. The prefrontal cortex (PFC) plays a crucial role in executive functions and other higher-order cognitive processes, with dysfunctions in this area associated with various cognitive, emotional and behavioural changes. Despite the existence of established tools like the Dysexecutive Questionnaire (DEX), the PSI addresses limitations found in the literature, presenting a novel ecologically valid tool for assessing prefrontal symptoms. The current study, involving 226 English-speaking participants, lays a foundational step for validating the PSI for use in a new population. Semi-confirmatory factorial analysis revealed a unidimensional structure, mirroring the Spanish version with robust fit indicators. Additionally, in assessing convergent validity, the abbreviated version (PSI-20) exhibited high correlations with DEX scores and moderate correlations with Psychological Stress Scale and General Health Questionnaire-12 scores. These findings align with previous reports, supporting the PSI-20's measurement of similar constructs related to prefrontal cortex activity and mental health components. The results of this study overall highlight the PSI's potential contribution to advancing prefrontal symptom evaluation in clinical and non-clinical settings.</p>","PeriodicalId":197,"journal":{"name":"Journal of Neuropsychology","volume":"19 2","pages":"200-215"},"PeriodicalIF":1.8,"publicationDate":"2024-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142454308","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Cognitive assessment: More important than ever","authors":"Stefano F. Cappa","doi":"10.1111/jnp.12396","DOIUrl":"10.1111/jnp.12396","url":null,"abstract":"","PeriodicalId":197,"journal":{"name":"Journal of Neuropsychology","volume":"19 2","pages":"154-157"},"PeriodicalIF":1.8,"publicationDate":"2024-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142363627","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"From neuropsychology to embodied neuroscience: Introduction to the special issue on body representation and body transformations","authors":"Paul M. Jenkinson, Valentina Moro","doi":"10.1111/jnp.12395","DOIUrl":"10.1111/jnp.12395","url":null,"abstract":"","PeriodicalId":197,"journal":{"name":"Journal of Neuropsychology","volume":"19 S1","pages":"1-7"},"PeriodicalIF":1.8,"publicationDate":"2024-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142277675","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}